Coalition Spotlight - Dr. Beatrice Wiafe Addai
NCC is proud to work in Ghana with Dr. Wiafe, an internationally respected and highly decorated breast cancer specialist in General Surgery & Breast Pathology. More
NCC and BD to Implement Cervical Cancer Detection Program in Peru
NCC and BD, a global medical technology leader, are pleased to announce the implementation of a cervical cancer early detection program to benefit 75,000 underserved women in Peru. More
NCC Provides Program Assists American Patients
The NCC Provides relief program is providing required Factor VIII and Factor IX therapies to a number of special summer camps in the United States for children with hemophilia. More
-
Pfizer
NCC is a preferred partner of Pfizer, the world’s largest pharmaceutical company. Over the past years, NCC has worked with Pfizer to assist underserved patients with access to numerous medicines for hemophilia, cancer, depression,…
Read This Case Study -
Merck
Merck & Co., in partnership with its Merck Sharp & Dohme (MSD) affliate, and the National Cancer Coalition collaborate on a number of targeted pharmaceuical donations to help provide access to cancer-related therapies in Latin America.…
Read This Case Study -
TEVA
TEVA Pharmaceuticals USA and the National Cancer Coalition have partnered for the past decade to assist underserved patients in gaining access to the medicines that they require. During this timeframe, NCC has received and then provided…
Read This Case Study -
Hospira
NCC is pleased to announce that it recently received a $25,000 grant award from the Hospira Foundation, the philanthropic arm of Hospira, Inc., to support its pharmaceutical relief program within the Dominican Republic. NCC is seeking…
Read This Case Study -
Genzyme
Genzyme Corporation and the National Cancer Coalition have a rich history of collaboration to provide underserved patients in the developing world patients with access to modern biotechnology medicines to treat liposomal storage disorders…
Read This Case Study
